Skip to content
LiveNext 14:28:29
SettledBusiness

OpenAI acquires Orchestra Bio to build AI agents for drug development

OpenAI announced Oct. 20 that it acquired Orchestra Bio, a four-year-old startup whose AI agents handle drug discovery operations such as finances and clinical trial scheduling, per TechCrunch. The team will work on Rosalind, OpenAI's life sciences model, and Rosalind Workbench. Terms were not disclosed.

HEAT
OUTLETS
16
FIRST SEEN
LAST SIGNAL

Primary source

TechCrunchtechcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%E2%81%A0-to-beef-up-its-biotech-business/

Coverage · 18 articles, oldest first

Share
Share card: OpenAI acquires Orchestra Bio to build AI agents for drug development

Share this article

Copying the image…

Open any post or message and paste it in. The link to TopFive is printed on the card.

Post it on

XLinkedInHacker NewsEmail
← The whole wire